使用甲氨蝶呤对银屑病进行全身治疗。
Systemic therapy of psoriasis using methotrexate.
作者信息
Smith K C
出版信息
Skin Therapy Lett. 2000;6(3):1-2; 5.
PMID:11176041
Abstract
If methotrexate were introduced as a new drug today, it would be hailed as a major advance in the management of psoriasis, as well as for a number of other conditions. Because the patent on methotrexate expired decades ago, this medication has not recently received the attention it deserves. When patients are properly screened and educated about the correct use of methotrexate, and appropriately monitored during treatment, this drug is a safe, inexpensive, well-tolerated and effective medication for the control of psoriasis.
摘要
如果甲氨蝶呤在今天作为一种新药推出，它将被誉为银屑病治疗以及其他一些病症治疗方面的一项重大进展。由于甲氨蝶呤的专利在几十年前就已过期，这种药物最近没有得到应有的关注。当患者经过适当筛查并接受关于正确使用甲氨蝶呤的教育，且在治疗期间得到适当监测时，这种药物是一种安全、廉价、耐受性良好且有效的控制银屑病的药物。
相似文献
1
Systemic therapy of psoriasis using methotrexate.
Skin Therapy Lett. 2000;6(3):1-2; 5.
2
[Methotrexate therapy in psoriasis].
Rev Prat. 2004 Jan 15;54(1):52-5.
3
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
J Am Acad Dermatol. 2009 May;60(5):824-37. doi: 10.1016/j.jaad.2008.11.906.
4
Methotrexate and other chemotherapeutic agents used to treat psoriasis.
Dermatol Clin. 1995 Oct;13(4):875-90.
5
Etanercept combined with methotrexate for high-need psoriasis.
Br J Dermatol. 2008 Aug;159(2):460-3. doi: 10.1111/j.1365-2133.2008.08669.x. Epub 2008 Jun 28.
6
Methotrexate in the treatment of psoriasis.
Cutis. 1999 Nov;64(5):332-4.
7
Folic acid supplementation and methotrexate therapy for psoriasis.
J Am Acad Dermatol. 2006 Aug;55(2):366-7. doi: 10.1016/j.jaad.2006.01.072.
8
Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
Clin Exp Dermatol. 2006 Jul;31(4):520-4. doi: 10.1111/j.1365-2230.2006.02153.x.
9
[Eventration and methotrexate in psoriasis].
Ann Dermatol Venereol. 2010 Oct;137(10):672. doi: 10.1016/j.annder.2010.04.005. Epub 2010 Jun 8.
10
The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
Int J Dermatol. 2006 Aug;45(8):965-9. doi: 10.1111/j.1365-4632.2006.02911.x.
引用本文的文献
1
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159.
2
[Systemic treatments for psoriasis and psoriatic arthritis].
Hautarzt. 2016 Jun;67(6):464-71. doi: 10.1007/s00105-016-3812-4.
Zotero 插件